CLINICAL_TRIALS
trial_result
· 2025-07-31
Clinical Trial Update: A Study of JNJ-64281802 for the Prevention of Dengue Infection [Phase 2]
Summary
A Phase 2 study of JNJ-64281802 for the prevention of dengue infection was terminated, with results posted on 2025-07-31.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Dengue | Phase 2 | Status: TERMINATED | Results posted: 2025-07-31